Company News: Page (1) of 1 - 04/03/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

European Commission Approves Expanded Indication For Amgen's XGEVAŽ (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma

This Approval was Based on the Largest International Trial Ever Conducted for the Prevention of Skeletal-Related Events in Multiple Myeloma Patients (April 03, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Manufacturing,Sales,Applications,Suppliers,Manufacturing/Production,Marketing,Insurance,Shipping & Receiving,Manufacturing,Sales & Marketing,Security,Database,Business Issues,Administration,Legal,Other,Management,Sales,Sales,USA,IT (Information Technology),Security,Medicine,Disease,Surgery,
Related Sites: DMN Newswire ,   IBN - Business ,   IBN - ProductivityApps ,   IBN - Security ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved